LRP5 and prostate carcinoma: Analogously, silencing of LRP5 in prostate cancer cells leads to a robust decrease in invasion growth and skeletal metastasis in vitro and in vivo by decreasing the expression of pro‐invasive and pro‐metastatic genes.26